SEC Form 4 · accession 0001179110-16-027933

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Miles D White

Officer — Chairman and CEO · Director

Period of report

Jul 25, 2016

Accepted (ET)

Jul 27, 2016 · 4:27 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common shares without par value	Jul 25, 2016	M	550,000	$25.2461	A	2,010,517	D
Common shares without par value	Jul 25, 2016	P	3,647	$43.155	A	2,014,164	D
Common shares without par value	Jul 25, 2016	P	13,500	$43.29	A	2,027,664	D
Common shares without par value	Jul 25, 2016	P	20,602	$43.22	A	2,048,266	D
Common shares without par value	Jul 25, 2016	P	7,300	$43.14	A	2,055,566	D
Common shares without par value	Jul 25, 2016	P	300	$43.065	A	2,055,866	D
Common shares without par value	Jul 25, 2016	P	3,800	$43.24	A	2,059,666	D
Common shares without par value	Jul 25, 2016	P	35,664	$43.08	A	2,095,330	D
Common shares without par value	Jul 25, 2016	P	12,600	$43.19	A	2,107,930	D
Common shares without par value	Jul 25, 2016	P	3,220	$43.145	A	2,111,150	D
Common shares without par value	Jul 25, 2016	P	1,800	$43.185	A	2,112,950	D
Common shares without par value	Jul 25, 2016	P	2,100	$43.16	A	2,115,050	D
Common shares without par value	Jul 25, 2016	P	8,700	$43.15	A	2,123,750	D
Common shares without par value	Jul 25, 2016	P	100	$43.32	A	2,123,850	D
Common shares without par value	Jul 25, 2016	P	1,900	$43.115	A	2,125,750	D
Common shares without par value	Jul 25, 2016	P	7,080	$43.18	A	2,132,830	D
Common shares without par value	Jul 25, 2016	P	3,504	$43.225	A	2,136,334	D
Common shares without par value	Jul 25, 2016	P	100	$43.1525	A	2,136,434	D
Common shares without par value	Jul 25, 2016	P	9,100	$43.235	A	2,145,534	D
Common shares without par value	Jul 25, 2016	P	9,198	$43.265	A	2,154,732	D
Common shares without par value	Jul 25, 2016	P	6,758	$43.25	A	2,161,490	D
Common shares without par value	Jul 25, 2016	P	100	$43.2725	A	2,161,590	D
Common shares without par value	Jul 25, 2016	P	200	$43.335	A	2,161,790	D
Common shares without par value	Jul 25, 2016	P	10,300	$43.07	A	2,172,090	D
Common shares without par value	Jul 25, 2016	P	25,400	$43.09	A	2,197,490	D
Common shares without par value	Jul 25, 2016	P	6,575	$43.245	A	2,204,065	D
Common shares without par value	Jul 25, 2016	P	14,802	$43.26	A	2,218,867	D
Common shares without par value	Jul 25, 2016	P	23,598	$43.275	A	2,242,465	D
Common shares without par value	Jul 25, 2016	P	10,499	$43.105	A	2,252,964	D
Common shares without par value	Jul 25, 2016	P	100	$43.1725	A	2,253,064	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F1	$25.2461	Jul 25, 2016	M	550,000	D	Feb 16, 2010	Feb 15, 2017	Common shares	550,000	0	D

Explanation of responses

F1Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks

Form 1 of 5. The transactions reported on this Form 4 are part of a series of transactions pursuant to which Mr. White personally invested $45.5 million in cash to purchase a total of 1,281,500 shares on his own account, increasing his total ownership from 1,460,517 shares to 2,742,017 shares. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).